Campbell Wilson

Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs

Jonathan R.S. Arch, A. T. Ainsworth, Michael A. Cawthorne et al. · Nature · 1984 · 729 citations

Obesity, Metabolic Syndrome, Molecular Pharmacology +10

The rat lipolytic β-adrenoceptor: Studies using novel β-adrenoceptor agonists

Campbell Wilson, Shelagh Wilson, Valerie Piercy et al. · European Journal of Pharmacology · 1984 · 155 citations

Molecular Pharmacology, Medicine, Physiology +6

Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat

Robin E. Buckingham, Thomas C. Hamilton, David Howlett et al. · British Journal of Pharmacology · 1989 · 119 citations · Full text

Molecular Pharmacology, Molecular Physiology, Biochemistry +15

Treatment of obesity with thermogenic beta-adrenoceptor agonists: studies on BRL 26830A in rodents.

J R Arch, A. T. Ainsworth, Ronald D. Ellis et al. · PubMed · 1984 · 63 citations

Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil

Campbell Wilson, Martin C. Coldwell, David Howlett et al. · European Journal of Pharmacology · 1988 · 54 citations

Molecular Pharmacology, Vasorelaxant Activity, Hyperpolarization (Biology) +9